Sugi Predict

Sugi Predict / Compounds / SCHEMBL25210486

SCHEMBL25210486

SCHEMBL25210486

CC(C)(C)O[Si](C)(C)CCCN1CCNCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR4 P61073 2/20 0.44
▸ SIGMAR1 Q99720 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CHRM2 P08172 1/20 0.35
▸ CHRM4 P08173 1/20 0.35
▸ CHRM5 P08912 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ TRPV4 Q9HBA0 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ KDM1A O60341 1/20 0.34
▸ HRH2 P25021 1/20 0.33
▸ HRH1 P35367 1/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ GNAO1 P09471 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15492196 0.82 CXCR4 (0.46) CXCR4SIGMAR1SMN1; SMN2MEN1KMT2A
SCHEMBL4065753 0.81 CXCR4 (0.44) CXCR4SIGMAR1SMN1; SMN2MEN1KMT2A
SCHEMBL4063049 0.78 CXCR4 (0.42) CXCR4SIGMAR1SMN1; SMN2MEN1KMT2A
SCHEMBL29242951 0.77 CXCR4 (0.44) CXCR4SIGMAR1SMN1; SMN2MEN1KMT2A
SCHEMBL15489982 0.77 CXCR4 (0.49) CXCR4SIGMAR1SMN1; SMN2MEN1KMT2A
SCHEMBL28284562 0.77 CXCR4 (0.41) CXCR4SIGMAR1SMN1; SMN2MEN1KMT2A
SCHEMBL13532382 0.76 CXCR4 (0.50) CXCR4SIGMAR1SMN1; SMN2MEN1KMT2A
SCHEMBL4068475 0.76 CXCR4 (0.46) CXCR4SIGMAR1SMN1; SMN2MEN1KMT2A
SCHEMBL775087 0.74 CXCR4 (0.44) CXCR4SIGMAR1SMN1; SMN2MEN1KMT2A
SCHEMBL4065759 0.73 CXCR4 (0.43) CXCR4SIGMAR1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051488-A1 METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE-BASED POLYMER, MODIFIED CONJUGATED DIENE-BASED POLYMER, POLYMER COMPOSITION, CROSS-LINKED PRODUCT, AND TIRE ENEOS MATERIALS CORPORATION (JP) 2025-02-13 — — US disclosed
EP-4431533-A1 METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE POLYMER, MODIFIED CONJUGATED DIENE POLYMER, POLYMER COMPOSITION, CROSSLINKED BODY AND TIRE ENEOS Materials Corporation (JP) 2024-09-18 — — EP disclosed
CN-118234761-A Process for producing modified conjugated diene polymer, polymer composition, crosslinked material, and tire 株式会社引能仕材料 2024-06-21 — — CN disclosed
WO-2023085309-A1 METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE POLYMER, MODIFIED CONJUGATED DIENE POLYMER, POLYMER COMPOSITION, CROSSLINKED BODY AND TIRE 株式会社ＥＮＥＯＳマテリアル 2023-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051488-A1 METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE-BASED POLYMER, MODIFIED CONJUGATED DIENE-BASED POLYMER, POLYMER COMPOSITION, CROSS-LINKED PRODUCT, AND TIRE NR2E1, IGF1R, RTN4 CXCR4 1813/4885SIGMAR1 1692/4885SMN1; SMN2 764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.